Search

Samantha L. Shterengarts

Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
4131, 1623, 1626
Total Applications
2313
Issued Applications
1786
Pending Applications
96
Abandoned Applications
469

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16842866 [patent_doc_number] => 11014940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-05-25 [patent_title] => Thiazolidinone and oxazolidinone compounds and formulations [patent_app_type] => utility [patent_app_number] => 16/653223 [patent_app_country] => US [patent_app_date] => 2019-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17985 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/653223
Thiazolidinone and oxazolidinone compounds and formulations Oct 14, 2019 Issued
Array ( [id] => 17953465 [patent_doc_number] => 11479556 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-10-25 [patent_title] => Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway [patent_app_type] => utility [patent_app_number] => 15/734774 [patent_app_country] => US [patent_app_date] => 2019-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74710 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734774 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734774
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway Oct 13, 2019 Issued
Array ( [id] => 16985450 [patent_doc_number] => 11072606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-27 [patent_title] => Compositions and methods for treating diseases and conditions [patent_app_type] => utility [patent_app_number] => 16/600248 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19839 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600248 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/600248
Compositions and methods for treating diseases and conditions Oct 10, 2019 Issued
Array ( [id] => 18085500 [patent_doc_number] => 11535618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors [patent_app_type] => utility [patent_app_number] => 17/282521 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 803 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282521 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/282521
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Oct 3, 2019 Issued
Array ( [id] => 16168136 [patent_doc_number] => 10709675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Nutraceutical compositions comprising C60 and curcumin [patent_app_type] => utility [patent_app_number] => 16/589715 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1429 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/589715
Nutraceutical compositions comprising C60 and curcumin Sep 30, 2019 Issued
Array ( [id] => 15865961 [patent_doc_number] => 20200140384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => MODULATORS OF HEMOGLOBIN [patent_app_type] => utility [patent_app_number] => 16/588753 [patent_app_country] => US [patent_app_date] => 2019-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -57 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16588753 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/588753
Modulators of hemoglobin Sep 29, 2019 Issued
Array ( [id] => 17875497 [patent_doc_number] => 11447498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Fused tetracyclic compounds and uses thereof in medicine [patent_app_type] => utility [patent_app_number] => 17/276735 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34287 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 923 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276735 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/276735
Fused tetracyclic compounds and uses thereof in medicine Sep 26, 2019 Issued
Array ( [id] => 15363417 [patent_doc_number] => 20200017473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/579341 [patent_app_country] => US [patent_app_date] => 2019-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579341 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/579341
Amide-substituted pyridinyltriazole derivatives and uses thereof Sep 22, 2019 Issued
Array ( [id] => 15586337 [patent_doc_number] => 20200069703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE [patent_app_type] => utility [patent_app_number] => 16/578130 [patent_app_country] => US [patent_app_date] => 2019-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16578130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/578130
CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE Sep 19, 2019 Abandoned
Array ( [id] => 16238174 [patent_doc_number] => 20200255408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/575724 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52165 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575724 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/575724
INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF Sep 18, 2019 Abandoned
Array ( [id] => 17228578 [patent_doc_number] => 20210355134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 [patent_app_type] => utility [patent_app_number] => 17/280632 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280632 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/280632
Manufacture of compounds and compositions for inhibiting the activity of SHP2 Sep 17, 2019 Issued
Array ( [id] => 15586341 [patent_doc_number] => 20200069705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => NOVEL PARASITE THERAPY [patent_app_type] => utility [patent_app_number] => 16/564773 [patent_app_country] => US [patent_app_date] => 2019-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16564773 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/564773
Parasite therapy Sep 8, 2019 Issued
Array ( [id] => 17214406 [patent_doc_number] => 20210347743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => Processes for Preparing a MDM2 Inhibitor [patent_app_type] => utility [patent_app_number] => 17/272031 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272031 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/272031
Processes for preparing a MDM2 inhibitor Aug 29, 2019 Issued
Array ( [id] => 15267215 [patent_doc_number] => 20190382341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => BISMALEIMIDE AND METHOD FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 16/555675 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/555675
BISMALEIMIDE AND METHOD FOR PRODUCING THE SAME Aug 28, 2019 Abandoned
Array ( [id] => 17006996 [patent_doc_number] => 20210238157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => Novel Cannabinoids and Cannabinoid Acids and Their Derivatives [patent_app_type] => utility [patent_app_number] => 17/269732 [patent_app_country] => US [patent_app_date] => 2019-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269732 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269732
Cannabinoids and cannabinoid acids and their derivatives Aug 19, 2019 Issued
Array ( [id] => 15496225 [patent_doc_number] => 20200048301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => EPOXY-(METH)ACRYLATE MONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/538989 [patent_app_country] => US [patent_app_date] => 2019-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/538989
Epoxy-(meth)acrylate monomers and polymers and methods of making and using the same Aug 12, 2019 Issued
Array ( [id] => 16869955 [patent_doc_number] => 20210163422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS [patent_app_type] => utility [patent_app_number] => 17/263243 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263243 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/263243
Reagents based on a tertiary amine backbone to introduce chemical functionality in nucleic acids and sequence-controlled polymers Aug 8, 2019 Issued
Array ( [id] => 15454339 [patent_doc_number] => 20200039994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => HETEROARYL AMIDE COMPOUNDS AS STING ACTIVATORS [patent_app_type] => utility [patent_app_number] => 16/528062 [patent_app_country] => US [patent_app_date] => 2019-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 3612 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528062 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/528062
Heteroaryl amide compounds as sting activators Jul 30, 2019 Issued
Array ( [id] => 15435149 [patent_doc_number] => 20200031758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => CRYSTALLINE EPINEPHRINE MALONATE SALT [patent_app_type] => utility [patent_app_number] => 16/526286 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526286 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/526286
Crystalline epinephrine malonate salt Jul 29, 2019 Issued
Array ( [id] => 17905455 [patent_doc_number] => 11459298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Class of dicationic compounds as well as the preparative method and the use thereof [patent_app_type] => utility [patent_app_number] => 17/044520 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4283 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044520 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044520
Class of dicationic compounds as well as the preparative method and the use thereof Jul 23, 2019 Issued
Menu